Laboratory Medicine ›› 2020, Vol. 35 ›› Issue (2): 173-177.DOI: 10.3969/j.issn.1673-8640.2020.02.018
Previous Articles Next Articles
LIU Yixuan, GUO Lin, LU Renquan
Received:
2019-04-13
Online:
2020-02-29
Published:
2020-03-22
CLC Number:
LIU Yixuan, GUO Lin, LU Renquan. Research progress of AIDS related lymphoma diagnosis and treatment[J]. Laboratory Medicine, 2020, 35(2): 173-177.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2020.02.018
[1] | GOEDERT J J.The epidemiology of acquired immunodeficiency syndrome malignancies[J]. Semin Oncol,2000,27(4):390-401. |
[2] | BERAL V,PETERMAN T,BERKELMAN R,et al.AIDS-associated non-Hodgkin lymphoma[J]. Lancet,1991,337(8745):805-809. |
[3] | MEISTER A,HENTRICH M,WYEN C,et al.Malignant lymphoma in the HIV-positive patient[J]. Eur J Haematol,2018,101(1):119-126. |
[4] | ROBBINS H A,PFEIFFER R M,SHIELS M S,et al. Excess cancers among HIV-infected people in the United States[J]. J Natl Cancer Inst,2015,107(4):dju503. |
[5] | YANIK E L,TAMBURRO K,ERON J J,et al.Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US,2000 to 2011[J]. Infect Agent Cancer,2013,8(1):18. |
[6] | ARZOO K K,BU X,ESPINA B M,et al.T-cell lymphoma in HIV-infected patients[J]. J Acquir Immune Defic Syndr,2004,36(5):1020-1027. |
[7] | VOGT S,PATEL M,OMAR T,et al.Molecular diagnostics for AIDS lymphoma diagnosis in south Africa and the potential for other low- and middle-income countries[J]. J Glob Oncol,2018,4:1-6. |
[8] | MARKS M A,RABKIN C S,ENGELS E A,et al.Markers of microbial translocation and risk of AIDS-related lymphoma[J]. AIDS,2013,27(3):469-474. |
[9] | EPELDEGUI M,VENDRAME E,MARTÍNEZ-MAZA O. HIV-associated immune dysfunction and viral infection:role in the pathogenesis of AIDS-related lymphoma[J]. Immunol Res,2010,48(1-3):72-83. |
[10] | IMBEAULT M,OUELLET M,GIGUÈRE K,et al. Acquisition of host-derived CD40L by HIV-1 in vivo and its functional consequences in the B-cell compartment[J]. J Virol,2011,85(5):2189-2200. |
[11] | SHANNON-LOWE C,RICKINSON A B,BELL A I.Epstein-Barr virus-associated lymphomas[J]. Philos Trans R Soc B Biol Sci,2017,372(1732):20160271. |
[12] | 王迪,冯艳玲. HIV/AIDS 相关淋巴瘤研究进展[J]. 国际肿瘤学杂志,2015,42(6):475-477. |
[13] | TANAKA P Y,OHSHIMA K,MATSUOKA M,et al.Epstein-barr viral load is associated to response in AIDS-related lymphomas[J]. Indian J Hematol Blood Transfus,2014,30(3):191-194. |
[14] | OHMOTO A,MAESHIMA A M,TANIGUCHI H,et al.Histopathological analysis of B-cell non-Hodgkin lymphomas without light chain restriction by using flow cytometry[J]. Leuk Lymphoma,2015,56(12):3301-3305. |
[15] | CHATTERJEE T,SOMASUNDARAM V.Flow cytometric detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by using "MRD lite" panel[J]. Med J Armed Forces India,2017,73(1):54-57. |
[16] | YOSHIDA N,ODA M,KURODA Y,et al.Clinical significance of sIL-2R levels in B-cell lymphomas[J]. PLoS One,2013,8(11):e78730. |
[17] | WANG L,LIAO D Z,ZHANG J,et al.Clinical significance of serum soluble interleukin-2 receptor-α in extranodal natural killer/T-cell lymphoma (ENKTL):a predictive biomarker for treatment efficacy and valuable prognostic factor[J]. Med Oncol,2013,30(4):723. |
[18] | ARMITAGE J O.Staging non-Hodgkin lymphoma[J]. CA Cancer J Clin,2005,55(6):368-376. |
[19] | 郑铁生,鄢盛恺. 临床生物化学检验[M]. 北京:中国医药科技出版社,2015. |
[20] | MONTALBÁN C,ABRAIRA V,ARCAINI L,et al. Risk stratification for splenic marginal zone lymphoma based on haemoglobin concentration,platelet count,high lactate dehydrogenase level and extrahilar lymphadenopathy:development and validation on 593 cases[J]. Br J Haematol,2012,159(2):164-171. |
[21] | 马肖容,徐燕,王瑾,等. 254例非霍奇金淋巴瘤的临床疗效与预后分析[J]. 中国实验血液学杂志,2016,24(4):1044-1050. |
[22] | GASTAUD L,ROSSIGNOL B,PEYRADE F,et al.Role of radiotherapy in the management of non-Hodgkin lymphomas[J]. Cancer Radiother,2016,20(3):236-247. |
[23] | 杨小芸,沈丽达,龙庭凤,等. 1 326例非霍奇金淋巴瘤临床病理特点分析[J]. 中华肿瘤防治杂志,2016,23(9):605-609. |
[24] | BARTA S K,SAMUEL M S,XUE X,et al.Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma[J]. Ann Oncol,2015,26(5):958-966. |
[25] | HOFFMANN C J,GALLANT J E.Rationale and evidence for human immunodeficiency virus treatment as prevention at the individual and population levels[J]. Infect Dis Clin North Am,2014,28(4):549-561. |
[26] | CRUCIANI M,GATTI G,VACCHER E,et al.Pharmacokinetic interaction between chemotherapy for non-Hodgkin's lymphoma and protease inhibitors in HIV-1-infected patients[J]. J Antimicrob Chemother,2005,55(4):546-549. |
[27] | SOMBOGAARD F,FRANSSEN E J F,TERPSTRA WE,et al. Outcome effects of antiretroviral drug combinations in HIV-positive patients with chemotherapy for lymphoma:a retrospective analysis[J]. Int J Clin Pharm,2018,40(5):1402-1408. |
[28] | FOCÀ E,CAVAGLIÀ G,RUSCONI S,et al.Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment:an observational multicentre study[J]. HIV Med,2018,10:1111. |
[29] | RIBERA J M,ORIOL A,MORGADES M,et al.Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma:results of a phase Ⅱ trial[J]. Br J Haematol,2008,140(4):411-419. |
[30] | GOODMAN A,PATEL S P,KURZROCK R.PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas[J]. Nat Rev Clin Oncol,2017,14(4):203-220. |
[31] | CHANG E,RIVERO G,PATEL N R,et al.HIV-related refractory Hodgkin lymphoma:a case report of complete response to nivolumab[J]. Clin Lymphoma Myeloma Leuk,2018,18(2):e143-e146. |
[32] | PHILIP T,GUGLIELMI C,HAGENBEEK A, et al.Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma[J]. N Eng J Med,1995,333(23):1540-1545. |
[33] | RE A,CATTANEO C,ROSSI G.HIV and lymphoma:from epidemiology to clinical management[J]. Mediterr J Hematol Infect Dis,2019,11(1):e2019004. |
[34] | 刘保池,蔡瑞,朱同玉. 特殊感染外科新理念与新技术[M]. 上海:上海科技教育出版社,2017. |
[35] | THOMPSON L D,FISHER M S I,CHU W S,et al. HIV-associated Hodgkin lymphoma:a clinicopathologic and immunophenotypic study of 45 cases[J]. Am J Clin Pathol,2004,121(5):727-738. |
[36] | CARBONE A,GLOGHINI A,CARUSO A,et al.The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis[J]. Int J Cancer,2017,140(6):1233-1245. |
[37] | AYALA E,CHAVEZ J C,GOMEZ A,et al.Feasibility and efficacy of high-dose chemotherapy and autologous hematopoietic cell transplantation for HIV-associated lymphoma:a single-institution experience[J]. Clin Lymphoma Myeloma Leuk,2018,18(8):548-551. |
[1] | ZHAO Jing, LI Yongqin, LI Yan, FAN Weiguang, YANG Xuegang. Roles of IP-10,SAA,hs-CRP,PCT and CD4+ T cell count determinations in HIV/AIDS patients with opportunistic infection [J]. Laboratory Medicine, 2023, 38(8): 725-729. |
[2] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[3] | LU Xinli, LIU Yong, LI Yan, WANG Yingying, AN Ning, LIU Meng. Identification of near full-length genome structures of new HIV-1 recombinant strains [J]. Laboratory Medicine, 2023, 38(11): 1015-1019. |
[4] | SUN Qi, QU Xinyi, XU Li. Analysis on outcome of patients with indeterminate western-blot results of HIV-1 antibody [J]. Laboratory Medicine, 2022, 37(8): 741-744. |
[5] | FAN Weiguang, SU Miaomiao, MENG Juan, SHI Penghui, ZHANG Zhen. Changes and clinical significance of IP-10 for antiviral therapy in AIDS patients [J]. Laboratory Medicine, 2022, 37(3): 221-225. |
[6] | WANG Wanhai, MENG Zhen, YANG Ruonan, GAO Nan, WANG Qingfang, ZHANG Lei, WANG Meifen, MING Liang. Analysis of common patterns of HIV antibody banding by western blotting and its role in follow-up period [J]. Laboratory Medicine, 2020, 35(2): 95-99. |
[7] | SUN Bin, WANG Shan, QIAN Jun, TANG Zhenhua. Prenatal screening for 63 109 pregnant women in Shanghai [J]. Laboratory Medicine, 2017, 32(5): 386-389. |
[8] | WEI Shanqiu. Research progress on immune factors related with HIV infectious disease development [J]. Laboratory Medicine, 2015, 30(6): 646-649. |
[9] | GUO Chuan, JI Linying, WU Yaobo, LIN Jiemin, CHEN Wan. The band patterns of Western blotting in different clinical stages of HIV-1 infection/AIDS patients [J]. Laboratory Medicine, 2015, 30(2): 145-148. |
[10] | XIAO Minmin,WANG Yi,SHAO Hui,ZHANG Yan,LI Ping. Investigation of HCV co-infection among HIV-1 infected patients in the South of Anhui [J]. , 2014, 29(7): 705-707. |
[11] | WANG Peng 1,XIAO Qing 2,TAI Shuhong 1,YANG Simei 2,XUE Ximei 2,SONG Junhua 3,JIA Liting 1. The infection of hepatitis C virus and treponema pallidum among HIV single-infection couples in Queshan county [J]. , 2013, 28(2): 137-139. |
[12] | LI Bo;GU Dayong;SITU Bo;LI Zhengliang;YAN Xiaohui;LIU Qinlan;ZHENG Lei;WANG Qian. The construction and confirmation of HIV-1 electrochemically active–inactive switching molecular beacon [J]. , 2012, 27(5): 408-411. |
[13] | ZHANG Haiyan;WANG Wanhai;XIA Xueshan;WANG Yongheng;FENG Yue;SU Tianrong;ZHANG Xiaoyan. Investigation of HCV co-infection among HIV-1 infected patients in Dali city [J]. , 2012, 27(2): 141-144. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||